SurVaxM Brain Cancer Vaccine

PrintE-mail
Thursday, September 27, 2012

A new clinical research study at Roswell Park, developed by Robert Fenstermaker, MD, and Michael Ciesielski, PhD, will test a first-of-its-kind cancer “vaccine” that may prove effective against many forms of solid-tumor cancers.

Cancer Can't Win

More patients are being diagnosed with cancer every day.

Here at Roswell Park Cancer Institute, we must continue to do what we do best – to understand, prevent and cure cancer. Because if we don’t, cancer wins. And Cancer Can’t Win.

  • With more than 3,000 scientific, academic and medical minds – Cancer Can’t Win.
  • When we are leading an advanced genetic program and creating next generation cancer vaccines to prevent it – Cancer Can’t Win.
  • When we are starting 13 new companies to advance our discoveries and share them with the world – Cancer Can’t Win.

Learn more about why Cancer Can’t Win

close